A randomized trial (ISS 902) of didanosine versus zidovudine in previously untreated patients with mildly symptomatic human immunodeficiency virus infection.

Floridia, M; Vella, S; Seeber, A C; Tomino, C; Fragola, V; Weimer, L E; Ricciardulli, D; Milazzo, F; Gritti, F M; Mazzotta, F; Ranieri, S; Chiodo, F; Moroni, M; Cargnel, A; Bassetti, D; Giannini, V; Cremoni, L; Concia, E; Sinicco, A; Carosi, G; Alberici, F; Dianzani, F

Floridia, M; Vella, S; Seeber, A C; Tomino, C; Fragola, V; Weimer, L E; Ricciardulli, D; Milazzo, F; Gritti, F M; Mazzotta, F; Ranieri, S; Chiodo, F; Moroni, M; Cargnel, A; Bassetti, D; Giannini, V; Cremoni, L; Concia, E; Sinicco, A; Carosi, G; Alberici, F; Dianzani, F.

Affiliation

Floridia M; Laboratory of Virology, Istituto Superiore di Sanità, Ospedale LazzaroSpallanzani, University La Sapienza, Rome, Italy.

J Infect Dis ; 175(2): 255-64, 1997 Feb.

Article in En | MEDLINE | ID: mdl-9203645

Subject(s)

Anti-HIV Agents/therapeutic use; Didanosine/therapeutic use; HIV Infections/drug therapy; Zidovudine/therapeutic use; Acquired Immunodeficiency Syndrome/diagnosis; Adult; Anti-HIV Agents/adverse effects; Body Weight; CD4 Lymphocyte Count; Didanosine/adverse effects; Disease Progression; Female; HIV Core Protein p24/analysis; HIV Core Protein p24/blood; HIV Infections/mortality; Humans; Male; Risk; Zidovudine/adverse effects

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Zidovudine / HIV Infections / Didanosine / Anti-HIV Agents Type of study: Clinical_trials / Diagnostic_studies / Etiology_studies / Risk_factors_studies Limits: Adult / Female / Humans / Male Language: En Journal: J Infect Dis Year: 1997 Document type: Article Affiliation country: Italy Country of publication: United States

Search on Google

Add to My VHL

XML

PubMed Links